Biktarvy, formally known as biktarvy, represents a potent single-tablet therapy for controlling HIV infection. This drug integrates three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the the viral ability to copy within the body, remarkably decreasing the viral burden. For many individua